Business
Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and More
The chlorpheniramine maleate market is poised for growth due to rising allergic conditions, OTC antihistamine awareness, and pharmaceutical innovationDublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Chlorpheniramine Maleate Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering. The global Chlorpheniramine Maleate Market is poised for significant growth, propelled by the rise in allergic conditions, heightened awareness of over-the-co
About this update from Viatris Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The chlorpheniramine maleate market is poised for growth due to rising allergic conditions, OTC antihistamine awareness, and pharmaceutical innovation","length":150,"tagName":"p"},{"type":"text","content":"Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Chlorpheniramine Maleate Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering.","length":206,"tagName":"p"},{"type":"text","content":"The global Chlorpheniramine Maleate Market is poised for significant growth, propelled by the rise in allergic conditions, heightened awareness of over-the-counter (OTC) antihistamines, and advances in pharmaceutical formulations. Valued at USD 452.2 million in 2026, it is projected to grow to USD 649.1 million by 2033, marking a CAGR of 5.3% over the forecast period. This trend reflects the increasing demand for effective allergy management solutions, with chlorpheniramine maleate gaining traction across various therapeutic applications.","length":544,"tagName":"p"},{"type":"text","content":"Market growth is driven by the increasing prevalence of allergic rhinitis, hay fever, and other hypersensitivity reactions. Innovations in pharmaceutical research, such as the development of fast-dissolving tablets, syrups, and eye drops, are improving patient compliance and expanding therapeutic use. The proliferation of online pharmacy channels is also enhancing accessibility and market adoption.","length":401,"tagName":"p"},{"type":"text","content":"Drivers","length":7,"tagName":"p"},{"type":"text","content":"Several factors are fueling the chlorpheniramine maleate market growth:","length":71,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Rising Incidence of Allergic Conditions: There is a global rise in allergies, such as hay fever and anaphylaxis, spurred by e...